Scotland · NHS Scotland MSAN
NovoRapid® PumpCart® (insulin aspart) 100units/ml solution for injection 1.6ml
MSAN(2025)27 · Level 2 · issued 06 Jun 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| cartridges are in limited supply until 2027 and cannot support new patient initiations. | Limited supply | 2027 |
| 2. Alternative insulin aspart products including NovoRapid® vials remain available and can | Available | — |
| remains available and can support increased demand. | Available | — |
| 11. Please note: Trurapi® vials remain available but cannot currently support any increase in | Available | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2025:27
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
c67ec34698fdb79235c2141ad70116ab50a563779e14c548dab9b49ce252441esha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2025-27.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.